Emma Reeve - 03 Sep 2021 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role
Director
Signature
/s/ Emma Reeve
Issuer symbol
EDIT
Transactions as of
03 Sep 2021
Net transactions value
$0
Form type
4
Filing time
08 Sep 2021, 16:33:10 UTC
Previous filing
19 Jul 2021
Next filing
10 Sep 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EDIT Stock Option (right to buy) Award $0 +13,736 $0.000000 13,736 03 Sep 2021 Common Stock 13,736 $68.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on September 3, 2021 and is scheduled to vest over three years in equal yearly installments of one-third of the shares beginning on September 3, 2022 through September 3, 2024.